SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-041238
Filing Date
2023-04-04
Accepted
2023-04-04 08:40:26
Documents
18
Period of Report
2023-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm239286d1_8ka.htm   iXBRL 8-K/A 35747
2 EXHIBIT 23.1 tm239286d1_ex23-1.htm EX-23.1 2003
3 EXHIBIT 99.4 tm239286d1_ex99-4.htm EX-99.4 463664
4 EXHIBIT 99.5 tm239286d1_ex99-5.htm EX-99.5 154888
5 EXHIBIT 99.6 tm239286d1_ex99-6.htm EX-99.6 217864
6 EXHIBIT 99.7 tm239286d1_ex99-7.htm EX-99.7 73886
10 GRAPHIC tm239286d1_ex99-7img001.jpg GRAPHIC 2625
  Complete submission text file 0001104659-23-041238.txt   1247607

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA carm-20230307.xsd EX-101.SCH 3036
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE carm-20230307_lab.xml EX-101.LAB 34476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE carm-20230307_pre.xml EX-101.PRE 22597
12 EXTRACTED XBRL INSTANCE DOCUMENT tm239286d1_8ka_htm.xml XML 4454
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36296 | Film No.: 23795202
SIC: 2834 Pharmaceutical Preparations